Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066411
Filing Date
2025-05-08
Accepted
2025-05-08 08:00:17
Documents
60
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ikna-20250331.htm   iXBRL 10-Q 1960180
2 EX-31.1 ikna-ex31_1.htm EX-31.1 17736
3 EX-31.2 ikna-ex31_2.htm EX-31.2 17823
4 EX-32.1 ikna-ex32_1.htm EX-32.1 16655
  Complete submission text file 0000950170-25-066411.txt   6766298

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ikna-20250331.xsd EX-101.SCH 976169
63 EXTRACTED XBRL INSTANCE DOCUMENT ikna-20250331_htm.xml XML 948525
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40287 | Film No.: 25923956
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)